Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenner PLC Regulatory News (FENR)

  • There is currently no data for FENR

Acquisition

2 Feb 2015 07:00

RNS Number : 6949D
Fenner PLC
02 February 2015
 

02 February 2015

Fenner PLC ("Fenner")

Acquisition of Charter Medical Limited ("Charter")

Fenner is pleased to announce that its wholly owned subsidiary Fenner Drives, Inc. has acquired 100% of the share capital of Charter from its parent company Lydall, Inc. a publicly traded company (NYSE: LDL) headquartered in Connecticut. Charter will be integrated into Solesis Medical Technologies ("Solesis"), part of Fenner's AEP division.

The consideration of US$29.9m was satisfied in cash at completion and the transaction is expected to be earnings enhancing immediately upon acquisition.

Charter manufactures specialty single-use assemblies and Class I and Class II medical devices for the collection, processing, storage and filtration of biological and bioprocessing fluids. Charter also produces bio-containers and fluid management sets that serve a range of life science applications including biopharmaceutical manufacturing, cell therapy and cryogenic storage. Charter is a single site company based in Winston-Salem, North Carolina.

As at 31 December 2014, unaudited gross assets acquired were US$6.9m with underlying EBITDA (1) of US$3.3m for the 12 months to 31 December 2014 on sales of US$19.6m. 

The entire workforce of Charter have become employees of Fenner upon completion and will continue to be led by General Manager, Mr. Gael Peron.

Nick Hobson, CEO of Fenner PLC, commented:

"In common with all businesses in our AEP division, Charter applies its polymer technology to solving problems in performance-critical applications. Charter has a strong, established business in blood transfusion and filtration markets and has exciting opportunities in the bio-processing and regenerative medicine markets, in which Fenner is already active and which are experiencing rapid growth. 

The acquisition of Charter, which will provide an attractive addition to the capabilities and offerings of Solesis, continues Fenner's strategy to develop our medical business both organically and by acquisition."

For further information please contact:

 

Fenner PLC 01482 626501

Nick Hobson, Chief Executive

John Pratt, Finance Director

 

Weber Shandwick Financial 020 7067 0700

Nick Oborne / Tom Jenkins

 

 

(1) Adjusted for historic non-recurring items

 

Notes to editors:

 

Fenner PLC is a world leader in reinforced polymer technology, providing local engineered solutions for performance-critical applications. The Group operates through two divisions:

Engineered Conveyor Solutions: the ECS division, trading under the Fenner Dunlop, Fenner and Dunlop brand names, is a recognised leader in the global conveying market. The division offers a unique, comprehensive suite of products and services, which serve the conveying needs of mining, power generation and bulk handling markets.

Advanced Engineered Products: the AEP division uses advanced polymeric materials and technical expertise to provide high value-added solutions to customers' most challenging engineering problems. Customers are spread across a variety of end-user segments, including oil & gas and medical which account for some 40 per cent of divisional revenue, together with construction, transportation, automation and general industrial. AEP's trading names are recognised globally and include CDI Energy Products, EGC Critical Components, Hallite, AIP Precision Machining, Fenner Precision, Fenner Drives, James Dawson, Mandals, Secant Medical and Xeridiem.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUARWRVBAURAR
Date   Source Headline
21st Mar 201811:53 amRNSForm 8.3 - Fenner Plc
21st Mar 201810:20 amRNSForm 8.3 - Fenner plc
21st Mar 20189:51 amRNSForm 8.5 (EPT/NON-RI) - Fenner plc
21st Mar 20189:43 amRNSForm 8.5 (EPT/RI) - Fenner plc
21st Mar 20189:42 amRNSForm 8.5 (EPT/RI) - Fenner plc
21st Mar 20189:20 amRNSForm 8.3 - Fenner Plc
21st Mar 20189:20 amPRNForm 8.3 - Fenner PLC
21st Mar 20187:37 amRNSForm 8.5 (EPT/NON-RI) Fenner plc
21st Mar 20187:00 amRNSForm 8.3 - [Fenner PLC]
20th Mar 20183:21 pmRNSForm 8.3 - Fenner Plc
20th Mar 20183:10 pmRNSForm 8.3 - Fenner Plc
20th Mar 20183:09 pmRNSForm 8.3 - Fenner plc
20th Mar 20181:39 pmRNSForm 8.3 - Fenner Plc
20th Mar 20181:15 pmBUSForm 8.3 - Fenner plc
20th Mar 201811:56 amPRNForm 8.3 - Fenner Plc
19th Mar 20185:14 pmRNSOffer for Fenner plc
5th Mar 20187:00 amRNSAcquisition
1st Mar 201810:00 amRNSBlock listing Interim Review
19th Jan 20183:36 pmRNSDirector/PDMR Shareholding
12th Jan 201811:40 amRNSResult of AGM
11th Jan 20187:00 amRNSAGM Trading Update
20th Dec 20177:00 amRNSDirectorate Change
12th Dec 201711:27 amRNSDocuments available for viewing/Notice of AGM
15th Nov 20177:00 amRNSFinal Results
5th Oct 201712:35 pmRNSHolding(s) in Company
5th Sep 20173:14 pmRNSHolding(s) in Company
1st Sep 20179:41 amRNSBlock listing Interim Review
29th Aug 20177:00 amRNSAcquisition
22nd Aug 201711:26 amRNSHolding(s) in Company
17th Aug 20179:55 amRNSHolding(s) in Company
14th Aug 201710:12 amRNSHolding(s) in Company
25th Jul 20177:00 amRNSSupply Agreement & Disposal of S.A. Sales Branches
21st Jul 20177:00 amRNSAppointment of Joint Corporate Broker
13th Jul 201710:02 amRNSDirector/PDMR Shareholding - REPLACEMENT
13th Jul 20179:20 amRNSDirector/PDMR Shareholding
12th Jul 20173:06 pmRNSDirector/PDMR Shareholding
7th Jul 20177:00 amRNSTrading Update
3rd Jul 201710:47 amRNSDirector Declaration
20th Jun 201710:12 amRNSHolding(s) in Company
15th Jun 201710:13 amRNSHolding(s) in Company
2nd Jun 201712:03 pmRNSHolding(s) in Company
19th Apr 20177:00 amRNSHalf-year Report
18th Apr 201710:51 amRNSHolding(s) in Company
7th Mar 20173:56 pmRNSHolding(s) in Company
1st Mar 201711:16 amRNSBlock listing Interim Review
23rd Feb 20179:20 amRNSHolding(s) in Company
15th Feb 20179:38 amRNSDisposal
7th Feb 201712:35 pmRNSHolding(s) in Company
7th Feb 201710:33 amRNSHolding(s) in Company
27th Jan 20179:12 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.